Aromatase converts testosterone to estradiol (estrogen), creating a vicious cycle where increasing belly fat leads to lower testosterone, which in turn promotes more fat storage
Do not self-prescribe or alter the dosage without medical guidance
Within scientific literature and experimental settings, BPC 157 has attracted attention for studies involving cellular behavior, cell migration, vascular responses, and mechanisms related to tissue repair
That creates the conditions tissue needs to actually heal [1]
In its lawsuit, the OFA said that the FDAs decision to end the shortage was a reckless and arbitrary move and could deprive patients of a vital treatment for type 2 diabetes and obesity. In an interview with BioSpace last month, David Rosen, partner at Foley & Lardner, said that the lawsuit is a precedent in this area. Prior to the OFA suit, no one has ever challenged the FDAs decision to remove a therapy from the drug shortage list. The OFA case is still ongoing, with the next court update due on Thursday
